Exagen Inc   (XGN)
Other Ticker:  
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Exagen Inc

Business Description

Exagen Inc. is a leading diagnostic company that specializes in the development and delivery of advanced testing solutions for autoimmune diseases. The company was founded in 2002 and is headquartered in Albuquerque, New Mexico, with additional offices and laboratory facilities in California, Colorado, and Mexico.

Exagen Inc. focuses on providing comprehensive testing options to physicians and patients to accurately diagnose autoimmune diseases. Autoimmune diseases are conditions where the immune system mistakenly attacks and damages healthy tissues and organs in the body. These diseases can be difficult to diagnose due to their complex and varied symptoms, making accurate testing crucial for proper treatment.

The company*s flagship product is called AVISE? testing, which stands for advanced diagnostic solutions for autoimmune and inflammatory diseases. AVISE? testing utilizes a proprietary technology called Cell-Bound Complement Activation Products (CB-CAPs) to identify and quantify autoimmune disease biomarkers in patient samples. By measuring these biomarkers, AVISE? testing can help differentiate between different autoimmune diseases and provide insights into disease activity and progression.

Exagen Inc. offers a wide range of AVISE? tests, including AVISE? Lupus, AVISE? Vasculitis, AVISE? Rheumatoid Arthritis, AVISE? SLE Prognostic, and AVISE? CTD. These tests are designed to assist physicians in diagnosing and monitoring patients with conditions such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and other connective tissue diseases (CTDs).

The company*s laboratory facilities are certified under the Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) standards. This ensures the accuracy and reliability of their testing procedures, and they are committed to providing high-quality results to healthcare providers and patients.

In addition to their diagnostic testing services, Exagen Inc. also invests in research and development to continuously improve their testing methodologies and expand their test menu. They collaborate with leading academic institutions and healthcare professionals to stay at the forefront of autoimmune disease diagnostics. This commitment to innovation has allowed them to develop advanced testing solutions that are both sensitive and specific in detecting autoimmune diseases.

Exagen Inc. demonstrates a strong commitment to patient care and education. They offer various resources, including patient support programs, educational materials, and webinars, to help patients and their families better understand autoimmune diseases and navigate their healthcare journeys.

In summary, Exagen Inc. is a diagnostic company that specializes in providing advanced testing solutions for autoimmune diseases. With their proprietary AVISE? testing technology and dedication to research and development, they are making significant contributions to the field of autoimmune disease diagnostics.

View Company Supplier View Company Competition View Company Customers


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com